A gold nanoparticle-based microfluidic protein chip for tumor markers

Area of Science:

• Biotechnology
• Nanotechnology
• Analytical Chemistry

Background:

• Cancer diagnostics rely on accurate tumor marker detection.
• Existing methods can be time-consuming and require expensive equipment.
• Point-of-care (POC) diagnostics offer faster results in clinical settings.

Purpose of the Study:

• To develop a novel cancer protein chip for sensitive and rapid detection of carcinoma embryonic antigen (CEA).
• To integrate signal amplification using gold nanoparticles (AuNPs) and microfluidic technology.
• To assess the chip's potential for point-of-care (POC) cancer diagnostics.

Main Methods:

• Fabrication of a reversed-phase protein chip with direct protein deposition.
• Utilized a two-layer microfluidic system for sequential capture of CEA and antibody reaction.
• Employed AuNPs-labeled secondary antibodies and silver enhancement for signal amplification.
• Detected CEA using a protein chip based on nanotechnology.

Main Results:

• The protein chip detected CEA across a wide concentration range (5–50,000 ng/mL).
• Achieved high sensitivity with a limit of detection (LOD) below 1 pM.
• Demonstrated a quick detection procedure.
• Eliminated the need for high-cost instrumentation.

Conclusions:

• The developed cancer protein chip offers a sensitive and rapid method for CEA detection.
• The integration of nanotechnology and microfluidics enhances diagnostic capabilities.
• The chip shows significant potential for point-of-care (POC) cancer diagnostics due to its cost-effectiveness and speed.